Search research articles
Contact Us
Filters
Showing results (281-290 of 293) with videos related to
Page
of 30
Sort By:
Blood
|
May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
Eduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Bone Marrow Transplantation
|
June 2, 2025
Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population
Maria Rueda-Lara, Ingrid Barrera, Krishna V Komanduri, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Mycopathologia
|
February 5, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era
Christopher M Lopez, Jose F Suarez, Maria A Mendoza, et al.
Blood Advances
|
April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Noa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Blood Advances
|
May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study
Noa G Holtzman, Annie Im, Lauren M Curtis, et al.
British Journal of Haematology
|
September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
Forat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Ejhaem
|
March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemia
Sarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Transplantation and Cellular Therapy
|
January 15, 2026
Towards Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force
Alina Markova, Stephanie J Lee, Badri Modi, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 293) with videos related to
Sort By:
Page
of 30
Blood
|
May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT
Eduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Bone Marrow Transplantation
|
June 2, 2025
Psychosocial correlates of failure to complete hematopoietic stem cell transplants in a diverse population
Maria Rueda-Lara, Ingrid Barrera, Krishna V Komanduri, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Mycopathologia
|
February 5, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary Era
Christopher M Lopez, Jose F Suarez, Maria A Mendoza, et al.
Blood Advances
|
April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
Noa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Blood Advances
|
May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study
Noa G Holtzman, Annie Im, Lauren M Curtis, et al.
British Journal of Haematology
|
September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma
Forat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Ejhaem
|
March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemia
Sarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Transplantation and Cellular Therapy
|
January 15, 2026
Towards Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force
Alina Markova, Stephanie J Lee, Badri Modi, et al.
Page
of 30